Insud Pharma
Jørgen Matz has a strong background in clinical quality and pharmacovigilance. Jørgen currently serves as the Head of Global Clinical Quality & Pharmacovigilance at Insud Pharma, where they are responsible for managing the pharmacovigilance operations across five business units. Jørgen provides strategic supervision to line managers, pharmacovigilance staff, and medical and regulatory functions. Prior to this role, Jørgen worked at H. Lundbeck A/S for over 20 years, holding various senior positions related to medical safety and risk management, global safety and pharmacovigilance, and cardiovascular sciences. Jørgen also has experience in safety pharmacology and conducted cardiovascular research during their early career at The William Harvey Research Institute.
Jørgen Matz completed their Master of Science (M.Sc.) in Pharmacy from the University of Copenhagen in 1993. Jørgen then pursued a Doctor of Philosophy (Ph.D.) in Pharmacology and Toxicology from the same university from 1993 to 1997. Later, from 2013 to 2015, they obtained a Postgraduate Diploma in Pharmacovigilance from the University of Portsmouth.
This person is not in any offices
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.